Atienzar FA - Search Results

1

Evaluation of impedance-based label-free technology as a tool for pharmacology and toxicology investigations.

Atienzar FA, Gerets H, Tilmant K, Toussaint G, Dhalluin S. Atienzar FA, et al. Biosensors (Basel). 2013 Mar 15;3(1):132-56. doi: 10.3390/bios3010132. eCollection 2013 Mar. Biosensors (Basel). 2013. PMID: 25587404 Free PMC article.

2

Multiplexing cell viability assays.

Gerets HH, Dhalluin S, Atienzar FA. Gerets HH, et al. Among authors: atienzar fa. Methods Mol Biol. 2011;740:91-101. doi: 10.1007/978-1-61779-108-6_11. Methods Mol Biol. 2011. PMID: 21468971

3

The use of real-time cell analyzer technology in drug discovery: defining optimal cell culture conditions and assay reproducibility with different adherent cellular models.

Atienzar FA, Tilmant K, Gerets HH, Toussaint G, Speeckaert S, Hanon E, Depelchin O, Dhalluin S. Atienzar FA, et al. J Biomol Screen. 2011 Jul;16(6):575-87. doi: 10.1177/1087057111402825. Epub 2011 Apr 25. J Biomol Screen. 2011. PMID: 21518825

4

Predictivity of dog co-culture model, primary human hepatocytes and HepG2 cells for the detection of hepatotoxic drugs in humans.

Atienzar FA, Novik EI, Gerets HH, Parekh A, Delatour C, Cardenas A, MacDonald J, Yarmush ML, Dhalluin S. Atienzar FA, et al. Toxicol Appl Pharmacol. 2014 Feb 15;275(1):44-61. doi: 10.1016/j.taap.2013.11.022. Epub 2013 Dec 10. Toxicol Appl Pharmacol. 2014. PMID: 24333257

5

Comparison of a genomic and a multiplex cell imaging approach for the detection of phospholipidosis.

Tilmant K, Gerets HH, Dhalluin S, Hanon E, Depelchin O, Cossu-Leguille C, Vasseur P, Atienzar FA. Tilmant K, et al. Among authors: atienzar fa. Toxicol In Vitro. 2011 Oct;25(7):1414-24. doi: 10.1016/j.tiv.2011.04.010. Epub 2011 Apr 15. Toxicol In Vitro. 2011. PMID: 21515356

6

Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins.

Gerets HH, Tilmant K, Gerin B, Chanteux H, Depelchin BO, Dhalluin S, Atienzar FA. Gerets HH, et al. Among authors: atienzar fa. Cell Biol Toxicol. 2012 Apr;28(2):69-87. doi: 10.1007/s10565-011-9208-4. Epub 2012 Jan 19. Cell Biol Toxicol. 2012. PMID: 22258563 Free PMC article.

7

The automated micronucleus assay for early assessment of genotoxicity in drug discovery.

Tilmant K, Gerets HH, De Ron P, Cossu-Leguille C, Vasseur P, Dhalluin S, Atienzar FA. Tilmant K, et al. Among authors: atienzar fa. Mutat Res. 2013 Feb 18;751(1):1-11. doi: 10.1016/j.mrgentox.2012.10.011. Epub 2012 Nov 15. Mutat Res. 2013. PMID: 23159395

8

Determination of phospholipidosis potential based on gene expression analysis in HepG2 cells.

Atienzar F, Gerets H, Dufrane S, Tilmant K, Cornet M, Dhalluin S, Ruty B, Rose G, Canning M. Atienzar F, et al. Toxicol Sci. 2007 Mar;96(1):101-14. doi: 10.1093/toxsci/kfl184. Epub 2006 Dec 14. Toxicol Sci. 2007. PMID: 17175557

9

Selection of cytotoxicity markers for the screening of new chemical entities in a pharmaceutical context: a preliminary study using a multiplexing approach.

Gerets HH, Hanon E, Cornet M, Dhalluin S, Depelchin O, Canning M, Atienzar FA. Gerets HH, et al. Among authors: atienzar fa. Toxicol In Vitro. 2009 Mar;23(2):319-32. doi: 10.1016/j.tiv.2008.11.012. Epub 2008 Dec 10. Toxicol In Vitro. 2009. PMID: 19110050

10

In vitro screening of cell bioenergetics to assess mitochondrial dysfunction in drug development.

Tilmant K, Gerets H, De Ron P, Hanon E, Bento-Pereira C, Atienzar FA. Tilmant K, et al. Among authors: atienzar fa. Toxicol In Vitro. 2018 Oct;52:374-383. doi: 10.1016/j.tiv.2018.07.012. Epub 2018 Jul 17. Toxicol In Vitro. 2018. PMID: 30030051

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

30 results

Search Page